116 related articles for article (PubMed ID: 6661265)
1. Peroxidase-catalysed covalent binding of the antitumor drug 2N-methyl-9-hydroxy-ellipticine to proteins.
Auclair C; Meunier B; Paoletti C
Biochem Pharmacol; 1983 Dec; 32(24):3883-6. PubMed ID: 6661265
[No Abstract] [Full Text] [Related]
2. Bioactivation of the antitumor drugs 9-hydroxyellipticine and derivatives by a peroxidase-hydrogen peroxide system.
Auclair C; Paoletti C
J Med Chem; 1981 Mar; 24(3):289-95. PubMed ID: 7265115
[TBL] [Abstract][Full Text] [Related]
3. Peroxidase-catalysed oxidation of N2,N6-dimethyl-9-hydroxyellipticinium acetate. Evidence for the formation of an electrophilic quinone-iminium derivative.
Meunier G; Bernadou J; Meunier B
Biochem Pharmacol; 1987 Aug; 36(16):2599-604. PubMed ID: 3606658
[TBL] [Abstract][Full Text] [Related]
4. Mammalian peroxidases activate anticancer drug ellipticine to intermediates forming deoxyguanosine adducts in DNA identical to those found in vivo and generated from 12-hydroxyellipticine and 13-hydroxyellipticine.
Stiborová M; Poljaková J; Ryslavá H; Dracínský M; Eckschlager T; Frei E
Int J Cancer; 2007 Jan; 120(2):243-51. PubMed ID: 17066455
[TBL] [Abstract][Full Text] [Related]
5. Peroxidase-catalyzed covalent binding of the antitumor drug N2-methyl-9-hydroxyellipticinium to DNA in vitro.
Auclair C; Dugué B; Meunier B; Paoletti C
Biochemistry; 1986 Mar; 25(6):1240-5. PubMed ID: 3964674
[TBL] [Abstract][Full Text] [Related]
6. Evidence for electrophilic properties of N2-methyl-9-hydroxy ellipticinium acetate (Celiptium) from human biliary metabolites.
Bernadou J; Monsarrat B; Roche H; Armand JP; Paoletti C; Meunier B
Cancer Chemother Pharmacol; 1985; 15(1):63-5. PubMed ID: 4006051
[TBL] [Abstract][Full Text] [Related]
7. [Demonstration of the O-demethylation reaction catalyzed by a peroxidase: application to 9-methoxyellipticine].
Meunier G; Paoletti C; Meunier B
C R Acad Sci III; 1984; 299(15):629-32. PubMed ID: 6440666
[TBL] [Abstract][Full Text] [Related]
8. [Metabolism and pharmacokinetics of methoxy-9-ellipticine and its principal metabolite, hydroxy-9-ellipticine].
Lecointe P; Puget A
C R Seances Acad Sci III; 1983; 296(6):279-82. PubMed ID: 6405990
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of 2-methyl-9-hydroxyellipticinium acetate (NSC-264137) in cancer patients (phase I study).
Gouyette A; Huertas D; Droz JP; Rouesse J; Amiel JL
Eur J Cancer Clin Oncol; 1982 Dec; 18(12):1285-92. PubMed ID: 6891926
[TBL] [Abstract][Full Text] [Related]
10. Effects of the 6-alkyl substitution of ellipticine on the uptake by NIH-3T3 cells and on the cytotoxicity.
Deprés JP; Larue L; Paoletti J; Gouyette A
Anticancer Res; 1988; 8(1):191-6. PubMed ID: 3358635
[TBL] [Abstract][Full Text] [Related]
11. Role of cytochromes P450 and peroxidases in metabolism of the anticancer drug ellipticine: additional evidence of their contribution to ellipticine activation in rat liver, lung and kidney.
Stiborova M; Moserova M; Mrazova B; Kotrbova V; Frei E
Neuro Endocrinol Lett; 2010; 31 Suppl 2():26-35. PubMed ID: 21187821
[TBL] [Abstract][Full Text] [Related]
12. The biooxidation of cytotoxic ellipticine derivatives: a key to structure-activity relationship studies?
Meunier G; De Montauzon D; Bernadou J; Grassy G; Bonnafous M; Cros S; Meunier B
Mol Pharmacol; 1988 Jan; 33(1):93-102. PubMed ID: 3336351
[TBL] [Abstract][Full Text] [Related]
13. Peroxidase-catalyzed O-demethylation reactions. Quinone-imine formation from 9-methoxyellipticine derivatives.
Meunier G; Meunier B
J Biol Chem; 1985 Sep; 260(19):10576-82. PubMed ID: 4030757
[TBL] [Abstract][Full Text] [Related]
14. Binding of retelliptine, a new antitumoral agent, to serum proteins and erythrocytes.
Maulard C; Urien S; Bastian G; Tillement JP
Biochem Pharmacol; 1990 Aug; 40(4):895-8. PubMed ID: 2386553
[No Abstract] [Full Text] [Related]
15. Cytochrome P450- and peroxidase-mediated oxidation of anticancer alkaloid ellipticine dictates its anti-tumor efficiency.
Stiborová M; Rupertová M; Frei E
Biochim Biophys Acta; 2011 Jan; 1814(1):175-85. PubMed ID: 20576524
[TBL] [Abstract][Full Text] [Related]
16. [Sanguinarine and ellipticine cytotoxic alkaloids isolated from well-known antitumor plants. Intracellular targets of their action].
Faddeeva MD; Beliaeva TN
Tsitologiia; 1997; 39(2-3):181-208. PubMed ID: 9312909
[TBL] [Abstract][Full Text] [Related]
17. Oxidation of an antitumor drug ellipticine by peroxidases.
Poljaková J; Forsterová K; Sulc M; Frei E; Stiborová M
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Dec; 149(2):449-53. PubMed ID: 16601808
[TBL] [Abstract][Full Text] [Related]
18. Microbial transformations of natural antitumor agents: use of solubilizing agents to improve yields of hydroxylated ellipticines.
Chien MM; Rosazza JP
Appl Environ Microbiol; 1980 Oct; 40(4):741-5. PubMed ID: 7425624
[TBL] [Abstract][Full Text] [Related]
19. omicron-Quinone formation in the biochemical oxidation of the antitumor drug N2-methyl-9-hydroxyellipticinium acetate.
Bernadou J; Meunier G; Paoletti C; Meunier B
J Med Chem; 1983 Apr; 26(4):574-9. PubMed ID: 6834391
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxicity of and DNA adduct formation by ellipticine in human U87MG glioblastoma cancer cells.
Martinkova E; Dontenwill M; Frei E; Stiborova M
Neuro Endocrinol Lett; 2009; 30 Suppl 1():60-6. PubMed ID: 20027146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
